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Introduction
 Multiple organ failure resulting from severe 
sepsis is explained as the sum of dysfunction of cells 
constituting individual organs［1］. To date, various types 
of cell death as the final result of cellular dysfunction 
have been proposed. Necrosis, passive cell death, is 
prominent in cases of excessive pathogen invasion and 
has long been understood morphologically. However, 
since the dramatic discovery of the role of apoptosis, 
type I programmed cell death, in the pathology of sepsis
［2］, the focus has substantially shifted from necrosis 
to apoptosis in investigations of the pathophysiology of 
sepsis. The present article reviews the involvement of 
apoptosis in the pathology of severe sepsis and describes 
countermeasures against apoptosis in this condition. 
The findings regarding the involvement of autophagy, 
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SUMMARY
Multiple organ failure resulting from severe sepsis is explained as the sum of dysfunction of cells 
constituting individual organs. Different types of cell death as the final result of cellular dysfunction have 
been proposed based on their morphological features. In septic cell death, necrosis （cell disintegration 
associated with massive damage to neighboring cells） is prominent, while apoptosis （type I programmed 
cell death characterized by an orderly sequence of events） and subsequently autophagy （type II 
programmed cell death） have been attracting recent research interest. Autophagy （meaning “to eat 
oneself”） is primarily a mechanism for intracellular proteolytic degradation. Autophagy plays a role in not 
only nutrition supply as a starvation response but also degradation of non-essential organelles, elimination 
of pathogenic microorganisms, and tumor suppression, indicating that autophagy is an essential system 
for maintaining life. However, excessive autophagy induces cell death. The present article reviews the 
involvement of apoptosis and autophagy （two cell death processes that may potentially work as a two-
edged blade depending on the patient’s condition and disease stage） in the pathology of sepsis and discusses 
the feasibility of treating sepsis by controlling autophagy.
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type II programmed cell death, obtained to date are 
also reviewed, and the feasibility of treating sepsis by 
controlling autophagy is discussed. 
Cell death-three different types
 Cell death is morphologically classified into three 
types, necrosis, apoptosis, and autophagy. While 
the process of apoptosis （programmed cell death） 
mediated by a protease caspase has been clarified by 
molecular biological methodologies, necrosis has been 
considered an accidental （non-programmed） form 
of cell death. In necrosis, stimuli inducing cell death 
trigger the influx of calcium ions and activation of 
calpain. As plasma membrane channels are opened, the 
influx of extracellular fluid and leakage of lysosomal 
contents promote intracellular degradation process［3］. 
As a consequence, both the cytoplasm and nucleus 
disintegrate, and the cellular injury affects the entire 
tissue. The extracellular release of the nuclear DNA-
binding protein high mobility group box 1 （HMGB1） 
from the disintegrated nucleus induces further 
inflammation.
 In contrast, apoptosis is the form of physiological 
cell death that occurs in most cases, and it is the type of 
cell death associated with embryogenic morphogenesis 
and postnatal cell renewal of individual tissues. The 
apoptotic process starts with cell shrinkage, followed by 
nuclear compaction and loss of mitochondrial membrane 
potential （Figure 1）. Then, further cell shrinkage 
occurs, with plasma membrane blebbing and formation 
of apoptotic bodies. In parallel, there is nuclear 
fragmentation together with chromatin condensation. 
Finally, the shrunken cells and apoptotic bodies are 
phagocytized by neighboring cells such as macrophages. 
 The third type of cell death, autophagy, has 
recently gained increased attention from researchers. 
Autophagy is defined as the mechanism by which cell 
components are transferred to lysosomes （organelles 
responsible for intracellular digestion） within the same 
cell and degraded, and the degradation products, such 
as amino acids and fatty acids, are reused. This internal 
degradation within a cell constitutes the reason why this 
process is named “autophagy,” a term derived from the 
Greek “to eat” （“phagy”） “oneself” （“auto”）. The 
roles of autophagy include not only nutrition supply 
as a starvation response［4］but also recently identified 
roles such as degradation of non-essential organelles, 
elimination of pathogenic microorganisms, and tumor 
suppression, indicating that autophagy is a system that is 
essential to supporting life［5］. 
 On the other hand, excessive autophagy results in the 
Fig. 1　Three pathways of cell death Modified from ref.［3］with permission.
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demonstrated［14］, suggesting that this parameter as 
well as absolute lymphocyte count （ALC） may serve 
as useful biomarkers for determining the therapeutic 
effect of treatments for this condition. Furthermore, as 
the intestinal tract harbors many immunocompetent 
cells, enhanced apoptosis in intestinal epithelium and 
reduced proliferation of intestinal crypt cells have been 
reported in sepsis［15］. Administration of epidermal 
growth factor （EGF） in sepsis is thought to reduce 
apoptosis and contribute to suppressing cell death, cell 
proliferation, and cell migration［16］.
 On the other hand, persistent organ dysfunction 
induced by continued mediator production by activated 
neutrophils due to their delayed apoptosis in sepsis 
is problematic［17,18］. Accordingly, the different 
behaviors of different cells should be taken into 
consideration when selecting countermeasures against 
apoptosis in sepsis.
Programmed cell death-related genetic 
polymorphisms and sepsis
 We have reported that genetic polymorphisms 
influence the pathology of conditions such as sepsis during 
the acute stage［20-23］. To investigate programmed cell 
death-related genetic polymorphisms, a genotyping study 
using a commercial single-nucleotide polymorphism 
（SNP） chip capable of analyzing 2,100 genes and 
48,742 SNPs at one time was carried using samples 
from acute kidney injury, a frequent complication of 
sepsis［24］. The results demonstrated that minor alleles 
of two SNPs in the BCL2  gene, an anti-apoptotic gene, 
did not influence the outcome of sepsis but reduced 
the risk of developing acute kidney injury secondary 
to infection （rs8094315: odds ratio 0.61, P＝0.0002; 
rs12457893: odds ratio 0.67, P＝0.0002）. Another SNP 
in the SERPINA4  gene linked to the apoptotic pathway 
in the kidney was found to influence the development 
of septic kidney injury［24］. These findings were 
confirmed in multiple Caucasian cohorts. The P2X7 
receptor belongs to a family of ligand-gated ion channels 
activated by extracellular adenosine 5-triphosphate 
（ATP）, which is released in excessive amounts under 
enormous loss of organelles due to massive cytoplasmic 
vacuolization and induces cell death （Figure 1）. 
Autophagy has long been morphologically understood. 
According to Clarke［6］, cell death is classified as 
follows:
・apoptosis （type I programmed cell death）
・ autophagy-associated cell death （type II programmed 
cell death）
・necrosis-like cell death
 More recently, a new type of cell death, programmed 
necrosis （necroptosis）, induced by the activation of 
tumor necrosis factor receptor 1 （TNFR1） was proposed
［7］. The involvement of RIP kinase 3-dependent 
necrosis in the lethality of cecal ligation and puncture-
induced sepsis in mice has been reported［8］.
Apoptosis in sepsis
 The landmark study on the involvement of cell 
death in sepsis may be that by Hotchkiss and colleagues, 
who were the first to use organ specimens obtained at 
autopsy from patients with severe sepsis［9］. They found 
that, among the cells in the various vital organs of the 
septic patients, apoptotic cell death was observed more 
frequently than necrosis in lymphocytes and intestinal 
epithelial cells［9］. They further proposed that marked 
apoptosis might occur in splenic CD4＋ T cells in 
patients with severe sepsis and lead to acquired immune 
deficiency syndrome （AIDS）-like immunosuppression
［10］. Since this immunosuppression could induce 
immune paralysis and negatively impact the outcome 
of severe sepsis, this group has been working to 
alleviate the paralysis by adopting an approach to 
control apoptosis in immunocompetent cells［11-13］. 
A phase 1b/2a trial of anti-programmed death-ligand 
1 （PD-L1） antibody, an immune checkpoint inhibitor, 
in severe sepsis/septic shock is currently in progress in 
the United States （#BMS-936559: https://clinicaltrials.
gov/, accessed 31 January 2016）, and its extension 
to Japan and Europe is planned depending on the 
results. The clinical usefulness of programmed death 
1 （PD-1） expression on leukocytes for monitoring 
immune dysfunction in critically ill patients has been 
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certain pathological conditions. This receptor is regarded 
as a “death receptor” that mediates the induction of 
apoptosis in various cells, and it is also involved in 
the activation of inflammatory responses. A number of 
coding SNPs have been identified in the P2X7  gene, 
and an ex vivo investigation of their influence on ATP-
stimulated cytokine production is in progress［25］.
 On the other hand, the human immunity-related 
GTPase family M protein （IRGM） gene has been found 
to play an important role in the autophagic degradation 
of Mycobacterium bovis （BCG） in cultured human 
macrophages［26,27］. In addition, a number of IRGM 
SNPs （e.g., rs13361189, rs10065172） are thought to 
be involved in excessive inflammatory responses such 
as those observed in Crohn’s disease［28］. Therefore, 
genetic polymorphisms of IRGM SNPs were analyzed 
in 793 ICU patients using an SNP chip in a multicenter 
study conducted at ICUs in five tertiary emergency 
medical centers in Japan. The results demonstrated 
the involvement of the TT genotype of the SNP locus 
IRGM （＋313） （rs10065172） in the poor outcomes 
of patients with severe sepsis （Figure 2） and relatively 
low expression levels of IRGM mRNA caused by 
lipopolysaccharide （LPS）. This suggests the possible 
role of a decreased autophagic response to a septic insult 
in poorer outcomes.
 Before reviewing involvement of autophagy in 
sepsis, the types, membrane dynamics, and molecular 
mechanism of autophagy will be outlined.
Types of autophagy
 At least three different types of autophagy exist 
in mammalian cells［19］: （1） macroautophagy, （2） 
chaperon-mediated autophagy （CMA）, and （3） 
microautophagy. 
 In macroautophagy, substances and organelles are 
first surrounded by a membrane called a “sequestering 
membrane.” This membrane appears in the cytosol 
and fuses into a double-membrane vesicle known as 
an autophagosome, which surrounds the substrates to 
be degraded. Then, an autophagosome fuses with a 
lysosome. 
 In CMA, substrates to be degraded are recognized 
by a molecular chaperon, heat shock protein 70 （hsp70）, 
in the cytosol and directly pass through the lysosomal 
membrane for degradation.
 Microautophagy involves the direct trapping of 
organelles by the lysosomal membrane for subsequent 
degradation. 
 Among these three types of autophagy, macro-
autophagy exhibits the highest activity of proteolytic 
degradation and is capable of sequestering and degrading 
a wide variety of substrates, from protein molecules to 
organelles, in autophagosomes with a diameter of approxi-
mately 1 μm. Therefore, this process is a bulk degradation 
system, and the term “autophagy” generally refers to 
macroautophagy. Although another intracellular protein 
degradation system, the ubiquitin-proteasome system, 
consists of a large protein complex, autophagy involves 
membrane trafficking mediated by membrane dynamics.
Fig. 2 Comparison of the mortality between different genotype categories of the SNP at IRGM （＋313） 
（rs10065172）［54］. （a） The discovery cohort （P＝0.043, recessive model of the correlation/trend test; TT 
v （CC＋CT） in 125 SS patients）. （b） The multi-center validation cohort （P＝0.037, recessive model of the 
correlation/trend test; TT v （CC＋CT） in 271 SS patients）. （c） The combined cohort （P＝0.004, recessive 
model of the correlation/trend test; TT v （CC＋CT） in 396 SS patients）. SS, severe sepsis/septic shock
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Membrane dynamics and the molecular 
mechanism of autophagy
 When cells are exposed to stresses such as starvation, 
the autophagic mechanism is activated by type III 
phosphatidylinositol （PI） 3-kinase/Beclin 1 （Atg6） and 
other factors （Figure 3）. Multiple steps are involved in 
the membrane dynamics of autophagy: ①spontaneous 
formation of the sequestering membrane; ②extension 
of the sequestering membrane in the presence of Atg5-
12 and Atg16 complexes; ③fusion of the sequestering 
membrane to form a double-membrane autophagosome 
with a vesicle-like structure; and ④fusion of the outer 
membrane of the autophagosome with a lysosome to 
form an autophagolysosome and subsequently degrade 
the contents. Atg5-12 complexes （represented by the 
symbol ○ in Figure 3） dissociate from the membrane 
surface following autophagosome formation. On the 
other hand, LC3-II （Atg8-phosphatidyl ethanolamine 
（PE） complex） （represented by the symbol ● in Figure 
3） binds to the sequestering membrane in an Atg5-
12 complex-dependent manner and contributes to 
autophagosome formation. In contrast to the ubiquitin-
proteasome system described above, this system 
degrades bulk substrates such as proteins without any 
specific recognition process and is capable of degrading/
digesting organelles such as mitochondria （mitophagy） 
（see below）.
Autophagy in sepsis
 We hypothesized that autophagy, type II programmed 
cell death, might play an important role in the pathology 
of sepsis and performed an electron microscopic 
morphological investigation of autophagosomes in liver 
samples obtained from patients with severe sepsis［29］. 
The results demonstrated that there were significantly 
more autophagosomes in patients with severe sepsis than 
in control patients without sepsis［29］. This phenomenon 
was reproduced in liver tissue specimens obtained from 
mice with surgical sepsis induced by cecal ligation and 
puncture （CLP） 24 hours after surgery, which showed 
an increased number of autophagosomes in the liver 
during sepsis［29］. This is the first article documenting 
the involvement of autophagy in severe sepsis. To clarify 
whether the observed increase in autophagosomes 
indicated an enhancement of autophagy or resulted from 
the interruption of the autophagic process, further studies 
of autophagy flux were performed using liver samples 
obtained from CLP-mice. The results demonstrated a 
marked increase in the number of autophagic structures 
at an even earlier stage, 6 hours after operation （Figure 
4）. Furthermore, an increase in the amount of p62 
protein over time, reflecting the accumulation of 
autophagosomes, indicated the transient enhancement of 
autophagy flux in response to the septic insult, although 
there was a tendency for subsequent stagnation［30］. We 
Fig. 3　Membrane dynamics of autophagy
　An autophagosome and a lysosome fuse in a Rab7-dependent manner, a small GTP 
binding protein［55］. Rubicon was identified as an inhibitor of membrane fusion between 
autophagosomes and lysosomes［56］. 
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plays an important role in antigen presentation to CD4＋ 
T cells via major histocompatibility complex （MHC） 
class II molecules［36］. Similarly, for the process of 
antigen presentation to CD8＋ T cells via MHC class I 
molecules, the accumulation of viral antigen proteins in 
autophagosomes during herpes simplex virus （HSV）-1 
infection indicates the importance of autophagy in 
antigen processing［37］. In addition, deficiency of 
autophagy-related gene 5 （Atg5） was found to cause 
abnormalities in self-antigen presentation by MHC class 
II molecules on thymic epithelial cells［38］. Furthermore, 
an autophagic mechanism has been reported to be critical 
in the differentiation and survival of T lymphocytes［39］. 
Based on these findings, autophagy likely has many 
more roles in immune mechanisms than previously 
thought.
Autophagy in immunocompetent cells and sepsis
 As described earlier, the involvement of the 
apoptosis （ type I programmed cell  death） of 
recently observed a similar tendency in murine proximal 
tubular cells as well （unpublished data）, consistent with 
a previously reported increase in autophagosomes in 
specimens obtained at autopsy from septic patients［31］. 
In the murine sepsis model described above, inhibition 
of autophagy with chloroquine resulted in deterioration 
of liver function and an increase in the mortality rate
［30］, while stimulation of autophagy with rapamycin 
normalized the serum cystatin C level, a marker of 
renal dysfunction （unpublished data）. These findings 
suggested the transient enhancement of autophagy in 
these organs as a part of the biological defense during 
the subacute stage of sepsis.   
Autophagy and immune mechanisms
 While autophagy has attracted the attention of 
researchers due to its role in innate immune responses 
against pathogenic microorganisms［32-35］, a portion 
of endogenous Epstein-Barr virus nuclear antigen 1 
（EBNA1） following degradation in autophagolysosomes 
0
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Fig. 4　Electron microscopic analysis of the liver in CLP mice
　（A） The number of autophagosomes and autolysosomes are compared between CLP and sham animals. 
All data are expressed as the mean±SD. Data were analyzed for statistical significance using the Mann-
Whitney test. The increase in autolysosomes in the CLP group was statistically significant （*P＜0.05; n＝3）; 
the mean increases in autophagosomes in the CLP group compared to the sham group did not reach statistical 
significance. NS, not significant. （B） Electron microscopic images of the liver; a: Liver sample obtained 
from sham-operated mice. Organelles in the hepatocyte are generally intact, and lysosomes do not contain 
discrete membrane structures, although the non-homogeneous electron-dense material often seen in （hetero）
lysosomes most certainly represents the end-stage degradation of phospholipids and other cytoplasmic 
materials （material at the light microscopic level referred to as lipofuscin）; b-e: CLP-operated mice. Double 
arrow heads indicate the complex structures bounded by two membranes （autophagosomes）; arrow heads 
indicate single membrane-bound lysosomal complexes with degraded organelle content （autolysosomes）; e: 
the double arrow head indicates an autophagosome that clearly contains a damaged mitochondrion.
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clinical and research interest in the effects of mitophagy 
in liver cells and skeletal muscle cells on the pathology 
of sepsis［29,42-44］. In clinical cases, activation of 
mitochondrial biogenesis in the skeletal muscle in 
septic patients is reported to contribute to a favorable 
outcome［43］, which implies that quality control of 
mitochondria by autophagy may play an important role 
in this condition［45］. We observed the accumulation 
of mitochondria in CD4＋ T cells in the CD4-Cre/
Atg5f/f mice described above （Oami, et al. submitted to 
“Critical Care Medicine”）, indicating the accumulation 
of dysfunctional mitochondria in a septic insult.
Cross-talk among the three types of cell death
 According to a number of reports, inhibition of 
autophagy triggers apoptosis in cells［46,47］. Atg5 is 
cleaved by calpain, a protease that triggers necrosis, and 
induces apoptosis by binding to Bcl-xL, an anti-apoptotic 
transmembrane protein component of mitochondria［48］. 
It is also known that the anti-apoptotic Bcl2/Bcl-xL 
complex conjugates with Beclin 1 to inhibit autophagy
［49］. Thus, studies to clarify the cross-talk between the 
different mechanisms of cell death at various levels are 
currently in progress. We observed enhanced expression 
of PDCD1 , a pro-apoptotic gene, a significant reduction 
in BCL2 , an anti-apoptotic gene, and enhanced apoptotic 
activity in CD4＋ T cells in CD4-Cre/Atg5f/f mice （Oami, 
et al. submitted to “Critical Care Medicine”）. While 
mRNA expression in a model of an acute disease such as 
sepsis greatly varies over time and depends on cell type
［50］, we propose that substantial cross-talk may exist 
between autophagy and apoptosis upon the initiation of 
these two processes.
Control of autophagy
 As described above, the close involvement of 
autophagy during the onset of organ dysfunction in 
sepsis has been clarified. Accordingly, controlling 
autophagy is expected to be an effective measure to 
prevent or treat organ dysfunction in sepsis. There are 
several possible methods for controlling autophagy. For 
immunocompetent cells in sepsis has almost been 
proven［2,9,10］. Accordingly, the degree of autophagy 
（type II programmed cell death） was investigated in 
CD4＋ T cells exhibiting markedly enhanced apoptosis 
in sepsis. 
 First, when sepsis was induced by a CLP operation 
in GFP-LC3 mice containing fluorescence-labeled 
autophagosomes throughout their whole bodies［30,40］, 
a significant increase in the expression of LC3 in 
CD4＋ T cells was observed 24 hours after surgery, 
demonstrating an increase in autophagic structures. 
However, an increase in lysosomes and the accumulation 
of p62 were also observed in this animal model, which 
suggested the possibility that autophagy in sepsis might 
not be sufficient for biological defense. On the other 
hand, following a CLP operation in Atg5 conditional 
knockout mice （CD4-Cre/Atg5f/f） specifically lacking 
autophagy in T cells, a significant decrease in the 
number of CD4＋ T cells was observed at an early stage 
after the CLP surgery with a concomitant enhancement 
of apoptotic activity compared with the sham-operated 
animals （Oami, et al. submitted to “Critical Care 
Medicine”）.
Mitophagy and tissue dysoxia
 During the process of tissue dysoxia in severe 
sepsis, reactive oxygen species （ROS） are generated 
via activation of nuclear factor-kappa B （NF-κB）, 
and cells are exposed to substantial oxidative stress. 
ROS are also produced as byproducts of mitochondrial 
electron transport for ATP synthesis by the catalytic 
activities of enzymes, including NADPH-dependent 
oxidase （Nox）. The generated ROS damage organelles 
and DNA. On the other hand, since mitochondria have 
anti-oxidative mechanisms to eliminate ROS, oxidative 
stress is closely related to the quality control of damaged 
mitochondria that produce ROS. Furthermore, damaged 
mitochondria release cytochrome C into the cytoplasm, 
which induces apoptosis via the intrinsic pathway. 
Mitophagy is a process used for the selective autophagic 
removal of dysfunctional mitochondria［41］, and in 
the field of response to insult, there has been recent 
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example, autophagy is known to be induced not only by 
starvation stress but also by drugs such as rapamycin. 
On the other hand, biomolecules such as insulin 
and growth factors inhibit autophagy by activation 
of mammalian target of rapamycin （mTOR） via a 
downstream pathway. The drug bafilomycin A1 is also 
reported to inhibit autophagy by inhibiting the fusion of 
autophagosomes with lysosomes［51］. In addition, the 
harmful effects of overfeeding in acute conditions have 
long been concerned［52］, and the concept of permissive 
underfeeding has been widely recognized［53］. These 
facts imply that maintaining moderate nutrient starvation 
state to avoid autophagy suppression may potentially 
contribute to improvement of clinical conditions in 
severe sepsis. 
Conclusions
 Sepsis is a complex syndrome that can be triggered 
by infection by any pathogen and encompasses a 
wide variety of pathological conditions. Furthermore, 
interindividual differences in the immune/inflammatory 
response are also an important factor［20-23］. To 
address and overcome sepsis, a tough enemy, it is 
imperative for us intensivist to carefully consider the 
patient's immune status, nutritional status, interindividual 
differences, and disease stage after proper stratification 
and to not miss the therapeutic window, which can be 
very narrow. Monitoring and controlling programmed 
cell death as described in the present article may provide 
a breakthrough approach that will improve survival in 
septic patients. 
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